These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33870119)

  • 21. An analysis of response to neo-adjuvant chemotherapy in patients with locally advanced breast cancer with emphasis on pathological complete response.
    Narendra H; Thomas J; Ray S; Fernandes DJ
    Indian J Cancer; 2014; 51(4):587-92. PubMed ID: 26842205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant chemotherapy in non-metastatic breast cancer: a study on practice trends in a regional cancer treatment service.
    Ang E; Wewala N; Carroll R; Forgeson G; Anderson M; Fernando J; Jordan J; Isaacs R
    Intern Med J; 2020 Mar; 50(3):315-321. PubMed ID: 30989751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review and meta-analysis on the effect of neoadjuvant chemotherapy on complications following immediate breast reconstruction.
    Varghese J; Gohari SS; Rizki H; Faheem M; Langridge B; Kümmel S; Johnson L; Schmid P
    Breast; 2021 Feb; 55():55-62. PubMed ID: 33341706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response.
    Lee HC; Ko H; Seol H; Noh DY; Han W; Kim TY; Im SA; Park IA
    J Breast Cancer; 2013 Dec; 16(4):395-403. PubMed ID: 24454461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.
    Avci N; Deligonul A; Tolunay S; Cubukcu E; Fatih Olmez O; Ulas A; Hartavi M; Kurt E; Evrensel T
    J BUON; 2015; 20(1):45-9. PubMed ID: 25778295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients.
    Skarping I; Förnvik D; Heide-Jørgensen U; Sartor H; Hall P; Zackrisson S; Borgquist S
    Cancer Causes Control; 2021 Mar; 32(3):251-260. PubMed ID: 33377172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing Laparotomy with Robot-assisted Interval Debulking Surgery for Patients with Advanced Epithelial Ovarian Cancer Receiving Neoadjuvant Chemotherapy.
    Zhang Y; Grant MS; Zhang X; Paraghamian SE; Tan X; Clark LH
    J Minim Invasive Gynecol; 2021 Jun; 28(6):1237-1243. PubMed ID: 33248314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The predictive value of sentinel node biopsy in early breast cancer after neo-adjuvant chemotherapy: A prospective study.
    Najim O; Dockx Y; Huyghe I; van den Wyngaert T; Papadimitriou K; Tjalma WAA; Huizing MT
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():108-111. PubMed ID: 30145524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
    Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
    Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion-weighted MRI for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: evaluation with mono-, bi-, and stretched-exponential models.
    Suo S; Yin Y; Geng X; Zhang D; Hua J; Cheng F; Chen J; Zhuang Z; Cao M; Xu J
    J Transl Med; 2021 Jun; 19(1):236. PubMed ID: 34078388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer].
    Wang DF; Zhang GN; Peng CR; Shi Y; Shi XW
    Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):385-392. PubMed ID: 34154313
    [No Abstract]   [Full Text] [Related]  

  • 32. Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
    Ryu JM; Park S; Paik HJ; Nam SJ; Kim SW; Lee SK; Yu J; Bae SY; Kim I; Bang SI; Mun GH; Pyon JK; Jeon BJ; Lee JE
    Clin Breast Cancer; 2017 Jun; 17(3):204-210. PubMed ID: 28065399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to immunohistochemical markers' conversion after neoadjuvant chemotherapy in breast cancer patients: association between imaging and histopathologic analysis.
    Zhao Y; Wang X; Huang Y; Zhou X; Zhang D
    Clin Transl Oncol; 2020 Jan; 22(1):91-102. PubMed ID: 31006089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.
    Kobal B; Noventa M; Cvjeticanin B; Barbic M; Meglic L; Herzog M; Bordi G; Vitagliano A; Saccardi C; Skof E
    Radiol Oncol; 2018 Sep; 52(3):307-319. PubMed ID: 30210049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of breast conservation surgery in locally advanced breast cancer downstaged by neoadjuvant chemotherapy: a study in mastectomy specimens using simulation lumpectomy.
    Viswambharan JK; Kadambari D; Iyengar KR; Srinivasan K
    Indian J Cancer; 2005; 42(1):30-4. PubMed ID: 15805689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission mammography in the evaluation of interim response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
    Soldevilla-Gallardo I; Villaseñor-Navarro Y; Medina-Ornelas SS; Villarreal-Garza C; Bargalló-Rocha E; Caro-Sánchez CH; Gallardo-Alvarado LN; Hernández-Ramírez R; Arela-Quispe LM; García-Pérez FO
    Cancer Treat Res Commun; 2018; 16():24-31. PubMed ID: 31298999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contribution of neoadjuvant chemotherapy for operability of cancers of the uterine cervix].
    Sláma J; Cibula D; Freitag P; Fischerová D; Janousek M; Pavlista D; Strunová M; Zikán M; Jancárková N
    Ceska Gynekol; 2007 Apr; 72(2):116-9. PubMed ID: 17639733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes of serum miR34a expression during neoadjuvant chemotherapy predict the treatment response and prognosis in stage II/III breast cancer.
    Liu B; Su F; Li Y; Qi X; Liu X; Liang W; You K; Zhang Y; Zhang J
    Biomed Pharmacother; 2017 Apr; 88():911-917. PubMed ID: 28178621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
    Mokos M; Bašić-Jukić N
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative ultrasound in conservative surgery for non-palpable breast cancer after neoadjuvant chemotherapy.
    Ramos M; Díez JC; Ramos T; Ruano R; Sancho M; González-Orús JM
    Int J Surg; 2014; 12(6):572-7. PubMed ID: 24735893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.